is semaglutide a prescription drug FDA issues warning about some compounded versions of for diabetes, weight loss FBI issues safety warning about

May 12, 2025: More Patients Sue Because of Side Effects of Ozempic and GLP-1 Products There are 1,809 lawsuits pending against the companies that made and sold Ozempic, the semaglutide medicine used to treat things like diabetes and obesity

Diarrhea or constipation may intensify

Simpler alcohol guidance Drink less for better health with clear guidance on who should avoid alcohol entirely

Just tell them at security

If weight loss stalls before reaching your target, switching to tirzepatide often restarts progress

Quick Answer Retatrutide is a triple-action peptide that targets GLP-1, GIP, and glucagon receptors simultaneously, making it the most potent weight management compound currently in clinical development